Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Martin Swaans , Ben van den Branden , Marco Post , et al Added: 3 years ago
In Europe, mitral regurgitation (MR) is the second most common form of valvular heart disease needing surgery.1 Studies have shown that up to 50 % of patients with severe symptomatic MR are not referred to surgery, even if a surgical indication exists.1–3 Reasons for denying surgery include impaired left ventricular ejection fraction, a high operative risk, multiple comorbidities or advanced age… View more

Vascular Disease and Surgery

Imaging & Diagnostics
ESC 2019 - MITRA-FR - Prof Jean-François Obadia
Author(s): Jean-François Obadia Added: 4 years ago
Prof Jean-François Obadia (Civils Hospices of Lyon, FR) discusses 2-year follow-up of the MITRA-FR study: A randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation. Filmed on site at ESC 2019 by Radcliffe Cardiology. View more

Heart Failure

Intervention
Research Area(s) / Expertise:
Dr Martin Swaans is cardiologist at St Antonius Hospital Nieuwegein in the Netherlands. Dr Swaans specialises in cardiac imaging, particularly in electrophysiology and interventional procedures. He is a frequent speaker at conferences around the globe and a world authority for interventional imaging. DrSwaans is heavily involved in the development of cutting edge imaging technologies. View more
ESC Congress 2022 Imaging Highlights
Author(s): Valentina O Puntmann , Silvia Valbuena-López Added: 1 year ago

Imaging & Diagnostics

COVID-19
APSC Consensus Recommendations for MitraClip in MR
Author(s): Khung Keong Yeo , Jack Wei Chieh Tan , David WM Muller , et al Added: 2 years ago

Intervention
Author(s): Lindsay A Smith , Amit Bhan , Mark J Monaghan Added: 3 years ago
The field of non-coronary cardiac intervention is undergoing rapid expansion, driven by advances in technology and increasing demand for alternative, non-surgical therapies for common structural heart diseases. As a result, the volume, variety and complexity of percutaneous catheter-based procedures being performed in cardiac catheterisation laboratories are increasing. Traditionally, fluoroscopy… View more

Imaging & Diagnostics

Intervention
Author(s): Michele De Bonis , Ottavio Alfieri Added: 3 years ago
Degenerative mitral regurgitation (MR) represents a rather common pathology, affecting 1–2% of the general population. In patients requiring surgery for this disease, mitral valve repair is the standard of care. Whenever feasible it is preferable to prosthetic replacement, as it provides better preservation of left ventricular (LV) function, higher survival, lower rates of thromboembolism and… View more

Vascular Disease and Surgery

Intervention
Author(s): David Messika-Zeitoun , Jean-Michel Serfaty , Dominique Himbert , et al Added: 3 years ago
Functional mitral regurgitation is a regurgitation that occurs despite a structurally normal mitral valve as a consequence of left ventricular dysfunction. It is a common feature of both dilated and ischaemic cardiomyopathy, and the presence and degree of severity of mitral regurgitation is associated with an increased risk of death and congestive heart failure.1–3 Mechanisms leading to… View more

Imaging & Diagnostics
Contemporary Management of Secondary Mitral Regurgitation
Author(s): Kashish Goel , Colin M Barker , JoAnn Lindenfeld Added: 3 years ago
Heart failure (HF) is a growing epidemic, with an estimated 6.2 million adults (≥20 years) affected between 2013 and 2016 in the US.1 The prevalence is increasing and is expected to reach 8 million by 2030.1 Mitral regurgitation (MR) is common in HF patients, especially in those with ischaemia, left ventricular (LV) dysfunction or dilated cardiomyopathy. MR in the absence of structural… View more

Vascular Disease and Surgery

Heart Failure
Author(s): Bao Tran , Gregg C Fonarow Added: 3 years ago
Heart failure (HF) remains a major public health problem resulting in substantial morbidity, mortality and healthcare expenditures globally. The European Society of Cardiology (ESC) 2012 Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure and the American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) 2013 Guideline for the Management of Heart… View more

Standards & Guidelines

Heart Failure